Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline

Journals

Article Types

Countries / Regions

Search Results (4)

Search Parameters:
Keywords = sclerobanding

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
2 pages, 178 KiB  
Correction
Correction: Pata et al. Sclerobanding (Combined Rubber Band Ligation with 3% Polidocanol Foam Sclerotherapy) for the Treatment of Second- and Third-Degree Hemorrhoidal Disease: Feasibility and Short-Term Outcomes. J. Clin. Med. 2022, 11, 218
by Francesco Pata, Luigi Maria Bracchitta, Giancarlo D’Ambrosio and Salvatore Bracchitta
J. Clin. Med. 2023, 12(15), 5159; https://doi.org/10.3390/jcm12155159 - 7 Aug 2023
Viewed by 1143
Abstract
In the original publication [...] Full article
(This article belongs to the Special Issue Colorectal Surgery: Latest Advances and Prospects)
2 pages, 188 KiB  
Reply
Sclerobanding Is a Novel Technique for the Treatment of Second- and Third-Degree Hemorrhoidal Disease. Reply to Jongen et al. Comment on “Pata et al. Sclerobanding (Combined Rubber Band Ligation with 3% Polidocanol Foam Sclerotherapy) for the Treatment of Second- and Third-Degree Hemorrhoidal Disease: Feasibility and Short-Term Outcomes. J. Clin. Med. 2022, 11, 218”
by Francesco Pata, Luigi Maria Bracchitta, Giancarlo D’Ambrosio and Salvatore Bracchitta
J. Clin. Med. 2022, 11(11), 3078; https://doi.org/10.3390/jcm11113078 - 30 May 2022
Cited by 3 | Viewed by 1297
Abstract
We thank Johannes Jongen and colleagues for their correspondence [...] Full article
(This article belongs to the Section Gastroenterology & Hepatopancreatobiliary Medicine)
1 pages, 169 KiB  
Comment
Comment on Pata et al. Sclerobanding (Combined Rubber Band Ligation with 3% Polidocanol Foam Sclerotherapy) for the Treatment of Second- and Third-Degree Hemorrhoidal Disease: Feasibility and Short-Term Outcomes. J. Clin. Med. 2022, 11, 218
by Johannes Jongen, Jessica Schneider, Volker Kahlke and Tilman Laubert
J. Clin. Med. 2022, 11(9), 2495; https://doi.org/10.3390/jcm11092495 - 29 Apr 2022
Cited by 1 | Viewed by 1375
Abstract
Dr. Pata kindly tweeted the publication of the above-mentioned paper [...] Full article
7 pages, 556 KiB  
Article
Sclerobanding (Combined Rubber Band Ligation with 3% Polidocanol Foam Sclerotherapy) for the Treatment of Second- and Third-Degree Hemorrhoidal Disease: Feasibility and Short-Term Outcomes
by Francesco Pata, Luigi Maria Bracchitta, Giancarlo D’Ambrosio and Salvatore Bracchitta
J. Clin. Med. 2022, 11(1), 218; https://doi.org/10.3390/jcm11010218 - 31 Dec 2021
Cited by 18 | Viewed by 3141 | Correction
Abstract
Background: Sclerobanding is a novel technique combining rubber band ligation with 3% polidocanol foam sclerotherapy for the treatment of hemorrhoidal disease (HD). The aim of this study is to evaluate the feasibility, safety and short-term outcomes of sclerobanding in the treatment of second- [...] Read more.
Background: Sclerobanding is a novel technique combining rubber band ligation with 3% polidocanol foam sclerotherapy for the treatment of hemorrhoidal disease (HD). The aim of this study is to evaluate the feasibility, safety and short-term outcomes of sclerobanding in the treatment of second- and third-degree HD. Methods: A retrospective analysis of second- and third-degree HD cases from November 2017 to August 2021 was performed. Patients on anticoagulants or with other HD degrees were excluded. Follow-up was conducted at 1 month, 3 months, 6 months, 1 year and then every 12 months. Results: 97 patients with second- (20 pts; 20.6%) and third-degree (77 pts; 79.4%) HD with a mean age of 52 years (20–84; SD ± 15.5) were included. Fifty-six patients were men (57.7%) and forty-one women (42.3%). Median follow-up was 13 months (1–26 months). No intraoperative adverse events or drug-related side effects occurred. Minor complications occurred in four patients (4.1%) in the first 30 postoperative days and all resolved after conservative treatment at the 3-month follow-up visit. No mortality or readmissions were observed. Conclusions: Sclerobanding is a safe technique with a low rate of minor postoperative complications. Further studies on larger samples are necessary to establish the effectiveness and long-term outcomes of the technique. Full article
(This article belongs to the Special Issue Colorectal Surgery: Latest Advances and Prospects)
Show Figures

Figure 1

Back to TopTop